timestranscript.canadaeast.com — Hugo Robichaud, has been diagnosed with the rare and fatal cancer known as neuroblastoma. The youngster's best chance at survival is an experimental procedure involving chemotherapy and surgery, which is offered only at New York City's Memorial Sloan-Kettering Cancer Centre and will cost an estimated $430,000 U.S